An update of this lecture is available at: https://www.slideshare.net/MohammedGawad/membranous-nephropathy-234601451
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Rheumatology Sheet from Rheumatology Department, Faculty of Medicine, Zagazig University, Egypt.
Disclaimer : not my slide. Just uploading for my personal use..
An update of this lecture is available at: https://www.slideshare.net/MohammedGawad/membranous-nephropathy-234601451
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Rheumatology Sheet from Rheumatology Department, Faculty of Medicine, Zagazig University, Egypt.
Disclaimer : not my slide. Just uploading for my personal use..
summary of factors contributing to the pathogeesis of SLE and the events that lead to its associated tissue damage, from genetic and immunologic point of view
Want to spice up your next corporate presentation? Take it from us, Make your next presentation Out Of This World! Download this Presentation for a Tweet here: http://goo.gl/YEheL
ANA-tomy of Autoimmunity:Revisiting ANAAllan Corpuz
Autoantibodies are a hallmark of autoimmunity and, specifically, antinuclear antibodies (ANAs) together with anti-dsDNA antibodies and extractable nuclear antigens (ENAs) are the most relevant autoantibodies present in systemic autoimmune rheumatic diseases (SARDs), since they can be relevant for the classification, diagnosis, and monitoring of patients with connective tissue diseases (CTDs). We will review the past, present, and future of ANAs, showing the evolution that has taken place from aspects related to the services involved in ANA requests to the different techniques that have been developed for their determination to the role of standardization in interpretation for clinical practice.
The evaluation of back pain can be a pain in the neck or a back-breaking exercise, so to speak. However, the diagnosis hinges always on a focused History and Physical Exam and not really on labs or imaging. Knowing what to ask and where to look can make the evaluation of this all-too-common condition manageable for the internist.
This lecture focuses on the evaluation of low back pain and will guide the reader on the key points in the Hx and PE and prevent unnecessary testing/imaging. It also presents 3 "unusual" cases of low back pain which may be disabling if not recognized immediately.
Musculoskeletal Health Concerns of the Aging PopulationAllan Corpuz
A lecture on low back pain, osteoarthritis and soft tissue rheumatisms delivered to nurses, nursing attendants and institutional workers at the the Philippine General Hospital
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
1. Lupus
Allan D. Corpuz, MD, FPCP, DPRA
Section of Rheumatology
Department of Medicine
Philippine GENERAL HOSPITAL
2. Objectives
• Recognize the clinical manifestations of SLE
• Order the important diagnostic tests
• Enumerate the treatment modalities
• Know when and where to refer
• Counsel patients with the disease
16. In Summary
• What it Is
– Systemic
– Autoimmune
– Chronic
– Relapsing
– Inflammatory
– Often febrile
– Female
– Impaired Immune System
– Can be controlled
• What It is Not
– Uniformly fatal
– Hopeless
– Curable
25. Immunologic Disorder
• Anti-dsDNA
• Anti-Smith
• Positive finding of aPL Abs
– Abnormal serum concentration of IgG/IgM
Anticardiolipin Abs
– (+) test result for lupus anticoagulant
– False (+) serologic test for syphilis known to be (+) for
6mos and confirmed by T.pallidum immobilization or
FTA-Abs test
28. In Summary: SOAP BRAIN MD
• Serositis
• Oral Ulcer
• Arthritis
• Photosensitivity
• Blood disorder
• Renal Disorder
• ANA
• Immunologic Disorder
• Neurologic Disroder
• Malar rash
• Discoid Rash
At least
4 of the11
Fulfillment of these
criteria is NOT an
absolute requirement
for Dx
30. • Noclinical manifestation or lab testcan serve as
a definitivediagnostic test
• SLE is diagnosed based on a constellation of
characteristic signs and symptoms and lab
findingsin the appropriate clinical
context
31. Serologic Tests790 PART 7 | DIAGNOSTIC TESTS AND PROCEDURES IN RHEUMATIC DISEASES
Because of the character
ies among the ANA dis
lated to play a role in
antibodies, for instance
inflammation in SLE ne
tion, direct binding to
and/or intracellular pen
toxicity.6
Similarly, rib
anti-Ro/SSA, anti-La/S
cated in the pathogenes
tions by penetrating liv
antigens in the skin an
anti-Scl-70 (topoisome
levels of interferon (IFN
ous scleroderma and
anti-Ro/SSA-positive se
demonstrated to induc
adhesion molecule (ICA
However, autoantibo
account for disease path
activity by anti-Ro/SS
appears restricted to pa
tomatic individuals,12
an
I may be required for
antibodies.13
This may
among or effects of the
novel conformations or
cally sensitive conforma
thetase (HisRS), the targ
Jo-1–specific antibody, h
an apoptope (epitope e
SSA may be specific to
Table 55-1 Antinuclear Antibody (ANA)-
Associated Diseases and Related Conditions
Condition
Patients with
ANAs (%)
Diseases for Which ANA Testing Is Helpful for Diagnosis
Systemic lupus erythematosus 99-100
Systemic sclerosis 97
Polymyositis/Dermatomyositis 40-80
Sjögren’s syndrome 48-96
Diseases in Which ANA Is Required for Diagnosis
Drug-induced lupus 100
Mixed connective tissue disease 100
Autoimmune hepatitis 100
Diseases in Which ANA May Be Useful for Prognosis
Juvenile idiopathic arthritis 20-50
Antiphospholipid antibody syndrome 40-50
Raynaud’s phenomenon 20-60
Some Diseases for Which ANA Typically Is Not Useful
Discoid lupus erythematosus 5-25
Fibromyalgia 15-25
Rheumatoid arthritis 30-50
Relatives of patients with autoimmune disease 5-25
Multiple sclerosis 25
Idiopathic thrombocytopenic purpura 10-30
Thyroid disease 30-50
Patients with silicone breast implants 15-25
Infectious disease Varies widely
Malignancies Varies widely
Healthy (“Normal”) Individuals
≥1:40 20-30
≥1:80 10-12
≥1:160 5
≥1:320 3
32. Antinuclear Antibodies
• Anti-nuclear (or anticytoplasmic) Abs bind to cells fixed on a
slide
• Addition of a secondary Ab (with an attached fluorescent
dye)
• Dilution at 1:40 and 1:160 buffered solution
• The titer is a measure of the amount of ANA in the blood
(higher titer – more autoABs)
• Standardization: 30% of normal individuals will have a
positive test at 1:40 (sensitive)
• At 1:160, only 5% of normal individuals will have a positive
test (specific)
33. False Positives
• 32% in normal individuals (>1:40)
• 13% (>1:80)
• 3% (>1:320)
• Relatively constant over time
Tan
EM,
Feltkamp
TE,
Smolen
JS,
et
al.
Range
of
an(nuclear
an(bodies
in
"healthy"
individuals.
Arthri(s
Rheum
1997;
40:1601.
34. False Negatives
• From technical and physical nuances
• Method of substrate fixation, the solubility of the
antigen (eg, Ro, La, PCNA, and Ku), and the
localization of the antigen outside the nucleus (ie,
Jo-1 and single stranded DNA)
• There is rarely any need to request testing for
antibodies to DNA, Sm, RNP, Ro/SSa, or La/SSb
unless the ANA is known to be positive
• Elderly (<1:80 titer)
Tan
EM,
Feltkamp
TE,
Smolen
JS,
et
al.
Range
of
an(nuclear
an(bodies
in
"healthy"
individuals.
Arthri(s
Rheum
1997;
40:1601.
35. IF (1:160) vs ELIA
• ELIA: recombinant technology (using kits); faster,
no training needed
• Agreement: 87-95%
• Sensitivity: 69-98%
• Specificity: 81-98%
• Still with high # of false +
Jaskowski
TD,
Schroder
C,
Mar(ns
TB,
Mouritsen
CL,
Litwin
CM,
Hill
HR:
Screening
for
an(nuclear
an(bodies
by
enzyme
immu-‐
noassay.
Am
J
Clin
Pathol
1996,
105:468-‐473.
Bizzaro
N,
Tozzoli
R,
Tonu^
E,
Piazza
A,
Manoni
F,
Ghirardello
A,
Basse^
D,
Villalta
D,
Pradella
M,
Rizzo^
P:
Variability
between
methods
to
determine
ANA,
an;-‐dsDNA
and
an;-‐ENA
auto
an;bodies:
a
collabora;ve
study
with
the
biomedical
industry.
J
Immunol
Methods
1998,
219:99-‐107.
36. Interpretation
A negative or low titer ANA-IF in the
setting of low clinical suspicion of
rheumatic disease usually indicates the
absence of significant ANAs and
argues against the diagnosisof one of
the ANA diseases
37. When to treat
Although the ANA-IF pattern and titer may provide
insight into the specific auto-Ag(s) targeted,
as well as the potential likelihood of CTD,
such correlations should ONLY guide,
NOT absolutely determine, clinical
decisions
38. Some specific ANAs possess diagnostic significance
and would need follow-up with specialized assays
BUT ONLY IN THE SETTING OF STRONG
CLINICAL SUSPICION because:
1. the PPV of an ANA in the absence of other clinical
signs of CTD is low, in part because it may
precede clinical disease by many years
2. because of the relatively high incidence of ANA in
normal individuals
39. If specific testing is negativein the setting of
high clinical suspicion, repeat testing at a later
date may be warranted, because titers of such
autoantibodies can fluctuateover time,
irrespective of disease course.
40. General Guidelines
• -ANA testing is not helpful in confirming a
diagnosis of rheumatoid arthritis or osteoarthritis
therefore should not be used in such conditions.
• - ANA testing is not recommended to evaluate
fatigue, back pain or other musculoskeletal pain
unless accompanied by one or more of the clinical
features in favor of a CTD.
• - ANA testing should usually be ordered only once.
• - Positive ANA tests do not need to be repeated.
41. • - Negative tests need to be repeated only if there is a
strong suspicion of an evolving CTD or a change in
the patient's illness suggesting the diagnosis should
be revised.
• - A positive ANA test is important only in conjunction
with clinical evaluation and in the absence of
symptoms and signs of a CTD; a positive ANA test
only confounds the diagnosis.A positive ANA test can
also be seen in healthy individuals, particularly the
elderly or in a wide range of diseases other than CTD,
where it has no diagnostic or prognostic value.
Kavanaugh
A,
Tomar
R,
Reveille
J,
Solomon
DH,
Homburger
HA:
Guidelines
for
Clinical
Use
of
the
An;nuclear
An;body
Test
and
Tests
for
Specific
Auto
an;bodies
to
Nuclear
An;gens.
Arch
Pathol
Lab
Med
2000,
124:71-‐81.
Guidelines
and
Protocols
Advisory
CommiOee.
BCGuide-‐
lines.ca
2007.
44. IMPACT on LIFE
• Chronically fatigued: vicious cycle
• Inability to finish school and find jobs
• Inability to sustain jobs
• Depression and Anxiety
• Family Support
45. SUMMARY
• Systemic autoimmune chronic relapsing
inflammatory disease
• Protean Manifestations (SOAP BRAIN MD)
• No definitive diagnostic test
• Use and Interpret S/Sx and tests based on a
clinical context
• Poor HRQoL